HNSBF - Hansa Biopharma AB (publ) (HNSBF) Q2 2025 Earnings Call Transcript
2025-07-17 10:46:16 ET
Hansa Biopharma AB (publ) (HNSBF)
Q2 2025 Earnings Conference Call
July 17, 2025, 8:00 AM ET
Company Participants
C. Evan Ballantyne - CFO & Senior VP
Hitto Kaufmann - Senior VP, Chief R&D Officer
Monika Tornsen - COO & President of U.S.
Renee Aguiar-Lucander - Chief Executive Officer
Conference Call Participants
Douglas Dylan Tsao - H.C. Wainwright & Co, LLC, Research Division
Matthew Christopher Phipps - William Blair & Company L.L.C., Research Division
Sushila Hernandez - Unidentified Company
Presentation
Operator
Good day, and welcome to the Hansa Biopharma Second Quarter Earnings Conference Call. [Operator Instructions]. Please note today's event is being recorded. I would now like to turn the conference over to Renee Aguiar-Lucander, Chief Executive Officer. Please go ahead.
Renee Aguiar-Lucander
Thank you. Good afternoon, and good morning, everyone, and welcome to the Hansa Biopharma Conference Call to review Q2 and half year results for 2025. I'm Renee Aguiar-Lucander, CEO of Hansa Biopharma....
Hansa Biopharma AB (publ) (HNSBF) Q2 2025 Earnings Call Transcript